Studies have reported a worse prognosis in ALN-positive patients than in ALN-negative patients, so an accurate assessment of the status of ALN in breast cancer patients before treatment can optimize treatment strategies and improve outcomes [23, 24]. Here, ARLN is linked to breast cancer.